Blue Ocean Capital Sells China Cord Blood Stake To SanPower Group Unit

Li Dongmei
October 13, 2017 — 10:35 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: acquisition bank Beijing Blue Ocean Capital Group CCB International China China Cord Blood Corporation chinese currency Dollar finance Golden Meditech guangdong healthcare investment medicine Nanjing Private Equity Renminbi shenzhen zhejiang

Related News:

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

Middle Eastern Sovereign Wealth Funds Deepen Investment in China

November 10, 2023 — 23:35

KKR Leads $180 Million Series F Round In Newly-Minted Asian Unicorn Livspace

February 15, 2022 — 03:32

US-Listed Chinese Companies Rush To List In Hong Kong

January 28, 2021 — 07:25

Chinese Investors Jump On The SPAC Bandwagon

January 27, 2021 — 06:02

KKR Closes $3.9 Billion APAC Infrastructure Fund

January 12, 2021 — 00:32

SAIC Injects RMB500 Million In Chinese EV Maker WM Motor

September 12, 2020 — 03:10

Ardian Closes $19 Billion For Secondary Funds And Co-Investments

June 4, 2020 — 05:35

Softbank, Hillhouse Back Chinese Zillow-Like Real Estate Platform Shell Zhaofang

March 5, 2020 — 22:27